Evidence map›Paper›PMID 31889777›Full record

ArticleSaudi journal of biological sciences2019

Using complex II as an emerging therapeutic target for the treatment of muscle lesions.

Kefeng Li, Wei Han, Ying Zhao, Yujuan Qi, Yadan Li, Jun Bi, Yi Wang, Guijun Dong

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of biological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kefeng LiCollege of Sports and Health, Shandong Sport University, Jinan 250102, China.
Wei HanCollege of Sports and Health, Shandong Sport University, Jinan 250102, China.
Ying ZhaoCollege of Sports and Health, Shandong Sport University, Jinan 250102, China.
Yujuan QiCollege of Sports and Health, Shandong Sport University, Jinan 250102, China.
Yadan LiCollege of Sports and Health, Shandong Sport University, Jinan 250102, China.
Jun BiCollege of Sports and Health, Shandong Sport University, Jinan 250102, China.
Yi WangCollege of Sports and Health, Shandong Sport University, Jinan 250102, China.
Guijun DongCollege of Sports and Health, Shandong Sport University, Jinan 250102, China.
Shandong Sport University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After patients has been trapped into skeletal muscle injury, hypoxic and dysfunctional mitochondria brings about a crisis in energy supply that severely disrupts the repair of skeletal muscle. This study aims to elucidate injury-induced adaptations in the mitochondria and provide statistics for the role of complex II in instilling cells with energy under hypoxic conditions. Fifty-six male Wistar rats were divided into control, 12 h, 2 d, 5 d, 7 d, 10 d, 15 d, and 30 d postinjury groups. Contusion injury was made via an instrumented drop-mass technique delivering single impact to the posterior surface of the gastrocnemius of one limb of the rats. ROS levels, loss of mitochondrial membrane potential (MMP), activities of marker enzymes (miCK, LDH, and ALP), and activities of complexes I-III were determined. Our findings reveal that the first 2 d postinjury, especially at 12 h, is the period with most severe oxidative stress. After injury, the activities of mitochondrial complexes I-III display different behaviors based on time and various energy production mechanisms. Our results highlight that complex II participates in electron transport in the acute phase of blunt trauma. We proposed that CII could be a therapeutic target in muscle lesions.

Indexed as

Complex IIMitochondriaMuscle injuriesTime-course changes

Identifiers

PMID31889777
PMCPMC6923501
OpenAlexW2954993136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.